Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Public ClinicalTrials.gov record NCT07138898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT07138898
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- NYU Langone Health
- Other
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- Abatacept Biological
- Adalimumab Drug
- Anakinra Biological
- Azathioprine Drug
- Belimumab Biological
- Bimekizumab Biological
- Canakinumab Biological
- Certolizumab Drug
- Cyclosporine Drug
- Etanercept Drug
- Golimumab Drug
- Guselkumab Biological
- Hydroxychloroquine Drug
- Infliximab Drug
- Ixekizumab Biological
- Leflunomide Drug
- Methotrexate Drug
- Mycophenolate Drug
- Risankizumab Biological
- Rituximab Biological
- Secukinumab Biological
- Sulfasalazine Drug
- Tacrolimus Drug
- Tocilizumab Biological
- Tofacitinib Drug
- Upadacitinib Drug
- Ustekinumab Biological
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2025
- Primary completion
- Aug 31, 2027
- Completion
- Aug 31, 2027
- Last update posted
- Aug 23, 2025
2025 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| NYU Langone Health | New York | New York | 10016 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07138898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2025 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07138898 live on ClinicalTrials.gov.